Ramucirumab 8 / Paclitaxel 80, Adenokarzinom ösophagogastraler Übergang und Magen (PID327 V1.2)
Cimetidin (ATC A02BA01)
- FachInfo: Cimetidin (H2Blocker-ratiopharm® 200 mg/2 ml, Injektionslösung)
- PC Compound: Cimetidine
Dexamethason (ATC H02AB02)
- FachInfo: Dexamethason Dexa-ratiopharm 4 mg/8 mg Injektionslösung
- FachInfo: Dexamethason (Fortecortin, Merck, 0,5 mg, 2mg, 4mg, 8mg, p.o.)
- PC Compound: Dexamethasone
- PC Substance: Dexamethason
Dimetinden (ATC R06AB03)
- FachInfo: Dimentinden (Fenistil®, NOVARTIS, Dimetindenmaleat 1mg/ml, i.v.)
- PC Compound: Dimetinden
- PC Substance: Dimetinden
- PC Substance: Dimetindenmaleat
Paclitaxel (ATC L01CD01)
- EMA EPAR: Paclitaxel (paclitaxel hetero)
- FachInfo: Paclitaxel (Paclitaxel onkovis, 6 mg/ml, i.v.)
- PC Compound: Nab-paclitaxel
- PC Substance: Paclitaxel
- PMID: One-hour paclitaxel infusions: review of safety and efficacy.
- PMID: Paclitaxel (Taxol): phase I/II trial comparing 1-hour infusion schedules.
Ramucirumab (ATC L01FG02)
- EMA EPAR: Ramucirumab (cyramsa)
- FachInfo: Ramucirumab
- PC Substance: Ramucirumab